CLINICAL_TRIALS
trial_result
· 2022-11-16
Clinical Trial Update: Nicotinamide Riboside in Systolic Heart Failure [Phase 1, Phase 2]
Summary
Phase 1/2 trial investigating nicotinamide riboside for systolic heart failure; study completed with results posted in 2022.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Washington | Conditions: Heart Failure, Systolic | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2022-11-16